5/24
08:03 am
bctx
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Medium
Report
BriaCell Therapeutics Corp. (NASDAQ: BCTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.